- Case details
- Status—ActionProcedural applicationCategoryOther procedural
- Parties
- Claimants
- Sanofi SAOperating co.
- Sanofi Winthrop IndustrieOperating co.
- Sanofi-Aventis GmbHOperating co.
- Sanofi BelgiumOperating co.
- Sanofi-Aventis Deutschland GmbHOperating co.
- Sanofi S.r.l.Operating co.
- Sanofi B.V.Operating co.
- Sanofi - Produtos Farmaceuticos LdaOperating co.
- Sanofi ABOperating co.
- Sanofi A/SOperating co.
Representatives- Frédéric Chevallier-Herbert Smith Freehills Kramer LLP
Respondents- Accord Healthcare S.L.U.Operating co.
- Accord Healthcare GmbH (AT)Operating co.
- Accord Healthcare B.V.Operating co.
- Accord Healthcare GmbH (DE)Operating co.
- Accord Healthcare Italia SrlOperating co.
- Accord Healthcare, Unipessoal Lda.Operating co.
- Accord Healthcare ABOperating co.
- STADA Nordic ApSOperating co.
Representatives- Jules Fabre-Pinsent Masons
- Arjan Reijns-Pinsent Masons
- Louise Millot-Pinsent Masons
- Daniel Hoppe-Bonabry
- Christian Meyer-Maiwald
- Andreas Ledl-Maiwald
- Anja Lunze-Taylor Wessing
- Elisabeth Greiner-df-mp
- Division
- Munich LD
- Judges
- Technology
- ChemistryPharmaceuticals
- Language
- —
- First decided
- May 8, 2025
- EPO Opposition
- Glenmark Pharmaceuticals Europe Ltd2021-03-10
- Accord Healthcare LtdAdmissible2021-03-10
- Teva Pharmaceutical Industries Ltd.Admissible2021-03-10
- EVER Valinject GmbHWithdrawn2021-03-12
- Zentiva k.s.Admissible2021-03-12
- medac Gesellschaft für klinische Spezialpräparate mbHWithdrawn2021-03-22
- Fresenius Kabi Deutschland GmbHAdmissible2021-03-23
- Dr. Reddy's Laboratories Ltd.Admissible2021-03-31
- Betapharm Arzneimittel GmbHAdmissible2021-03-31
- Generics (U.K.) LimitedAdmissible2021-06-08
- Vossius & Partner Patentanwälte Rechtsanwälte mbBAdmissible2021-12-03
- STADA Arzneimittel AGAdmissible2021-12-09
- Maiwald GmbHAdmissible2021-12-10
- Accord Healthcare S.L.U.2024-08-30
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Munich LD | Locked |
| Judge Matthias Zigann | Locked |
At the UPC: Sanofi Group (33 cases)·Accord Group (8 cases)
This dispute contains 11 other proceedings
UPC CoA 22/2026·UPC CoA 25/2026·UPC CFI 106/2026·UPC CFI 108/2026·UPC CFI 496/2024 and 6 more
9 other defendants litigating the same or a related patent
UPC CoA 23/2026·UPC CoA 24/2026·UPC CoA 26/2026·UPC CoA 27/2026·UPC CFI 503/2024 and 4 more
- 2025-05-08
Summary: Lengthy procedural order from Munich Local Division in consolidated infringement proceedings by Sanofi entities against multiple generic pharmaceutical companies (Accord, STADA, Dr. Reddy's, Zentiva) concerning EP 2 493 466 (insulin glargine). The order (judge-rapporteur Zigann) addresses numerous procedural matters including damages assessment timing, stay pending EPO Board of Appeal proceedings, and schedule for further pleadings. No substantive ruling; oral hearing deferred to await EPO BoA outcome.
Show the legal issues (4)
- Insulin glargine biosimilar infringement
- Stay pending EPO Board of Appeal
- Calculation of damages in pharmaceutical infringement
- Counterclaims for revocation
- A4825AC715439669D057A6EAB2C73859_en.pdf2025-05-08EN